SEATTLE, Jan. 10, 2012 (GLOBE NEWSWIRE) -- Attorney Advertising. Keller Rohrback L.L.P. (www.krclassaction.com) is investigating reports that Pradaxa, an anti-coagulant medication, increases a user's risk of heart attack or chest pain. Pradaxa is manufactured by Boehringer Ingelheim GmbH (BING), and, according to BING, is prescribed for patients who have atrial fibrillation to reduce the risk of stroke and systemic embolism.
If you or someone you know were prescribed Pradaxa and experienced a heart attack, Acute Coronary Syndrome ("ACS"), or severe chest pain while taking the medication, please contact attorneys Mike Woerner or Mark Samson at (800) 776-6044 or via email at consumer@kellerrohrback.com.
Keller Rohrback, with offices in Seattle, Phoenix, New York and Santa Barbara is proud to offer its expertise in personal injury cases to clients nationwide.
Attorney Advertising. Prior Results Do Not Guarantee A Similar Outcome.